What is the evidence-based surgical management for a patient with severe stress urinary incontinence (SUI) and grade 2 cystocele who has failed conservative management, specifically regarding TVT (Tension-free Vaginal Tape) / TVTO (Tension-free Vaginal Tape Oburator) and cystocele repair?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Surgical Management for Severe Stress Urinary Incontinence with Grade 2 Cystocele

For a 51-year-old woman with severe stress urinary incontinence and grade 2 cystocele who failed conservative therapy, with urodynamics showing good compliance, stable detrusor, and stress-only leakage, a retropubic midurethral synthetic sling (RMUS) with concomitant cystocele repair is the recommended surgical approach.

Primary Surgical Options

Midurethral Synthetic Sling (MUS)

  • Retropubic midurethral sling (RMUS) is preferred over transobturator midurethral sling (TMUS) for this patient with severe SUI, as RMUS has demonstrated better long-term outcomes for severe cases 1
  • RMUS (such as TVT) has been extensively studied with long-term data showing durable efficacy, making it appropriate for severe SUI 1
  • While both RMUS and TMUS show similar short-term efficacy, RMUS may be more effective for patients with severe SUI 1
  • The selection between RMUS and TMUS should consider the risk profile differences: RMUS has higher risks of bladder perforation, vascular injury and voiding dysfunction, while TMUS has higher risks of groin pain and repeat incontinence surgery 1

Combined Approach for SUI and Cystocele

  • For patients with both SUI and cystocele, combined surgical correction is appropriate and supported by evidence 1, 2
  • Anterior colporrhaphy plus TVT has demonstrated excellent long-term outcomes with 10-year data showing 89% cure rates for both SUI and cystocele 2
  • Contemporary literature supports consideration of concomitant anti-incontinence procedure at the time of prolapse repair, with mean complete continence rates of 80% at 22-month follow-up 1
  • Combined surgery has shown lower rates of postoperative SUI compared to prolapse surgery alone, though with slightly higher rates of complications 1

Specific Considerations for This Patient

Evidence Supporting RMUS with Cystocele Repair

  • The patient's urodynamic findings (good compliance, stable detrusor, and leakage only with stress) make her an ideal candidate for MUS 1
  • Long-term data supports the durability of TVT with objective cure rates of 80-83% at 5-7 years 3
  • Combined TVT and anterior colporrhaphy for management of SUI with cystocele has shown success rates of 88.8% at 24 months 4
  • For patients with grade 2 cystocele and SUI, combined procedures have demonstrated effectiveness with 95% cure from cystocele and 91% cure from SUI at 10 years 2

Potential Complications and Management

  • The patient should be counseled about potential complications specific to MUS, including bladder perforation, urethral injury, mesh exposure, and voiding dysfunction 1
  • Combined surgery has higher rates of complications (28% vs 15%) compared to prolapse surgery alone, including bladder perforation, urethral injuries, and tape exposure 1
  • De novo detrusor overactivity can occur in approximately 9-11% of patients following TVT at 5-7 year follow-up 3
  • Late complications at 10-year follow-up for combined procedures include OAB symptoms (20%), mixed incontinence (2%), dyspareunia (6%), and vaginal tape erosion (4%) 2

Alternative Options

Autologous Fascia Pubovaginal Sling (PVS)

  • Autologous fascia PVS is an alternative for patients concerned about mesh complications or with contraindications to synthetic mesh 1
  • PVS has demonstrated 85-92% success rates with 3-15 years of follow-up 1
  • The SISTEr trial showed that PVS was more effective than Burch colposuspension with lower re-treatment rates (66% versus 49%) 1

Bulking Agents

  • Urethral bulking agents are viable but less effective options for patients who wish to avoid more invasive surgical management 1
  • Re-treatment is common with bulking agents, and patients should be counseled about the expected need for repeat injections 1
  • Limited long-term data exists for bulking agents, though some newer agents show persistence of effect at 73-96 months 1

Management of Recurrent SUI

  • If initial MUS fails, a repeat RMUS is considered the procedure of choice by experts 5, 6
  • Success rates for repeat MUS procedures have been reported as high as 91.7% 5

Preoperative Counseling

  • The patient must be thoroughly counseled regarding the specific risks and benefits of mesh as well as alternatives to mesh slings 1
  • Preoperative counseling regarding MUS mesh complications has been shown to result in reduced patient concern, greater willingness to proceed, and higher satisfaction 1
  • The patient should understand that success rates for combined procedures range from 80-95%, but complications may be higher than with single procedures 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.